{"prompt": "['Clinical Study Protocol', 'R2810-ONC-1676 Amendment 7', 'Pemphigoid', 'Pemphigus', 'Psoriasis', 'Rash', 'Rash erythematous', 'Rash generalised', 'Rash macular', 'Rash maculo-papular', 'Rash maculovesicular', 'Rash morbilliform', 'Rash papular', 'Rash pruritic', 'Rash rubelliform', 'Rash scarlatiniform', 'Rash vesicular', 'Skin reaction', 'Stevens-Johnson syndrome', 'Toxic epidermal necrolysis', 'Toxic skin eruption', 'Autoimmune heparin-induced thrombocytopenia', 'Heparin-induced thrombocytopenia', 'Immune thrombocytopenia', 'Immune thrombocytopenic purpura', 'Insulin autoimmune syndrome', 'Regeneron Pharmaceuticals, Inc.', 'Page 139 of 145', 'CONFIDENTIAL', 'VV-RIM-00146791-1.( Approved - 14 Apr 2021 GMT-5:00']['Clinical Study Protocol', 'R2810-ONC-1676 Amendment 7', 'Iridocyclitis', 'Iritis', 'Keratitis', 'Ulcerative keratitis', 'Meningitis', 'Meningitis aseptic', 'Motor dysfunction', 'Mucosal inflammation', 'Muscular weakness', 'Myalgia', 'Ocular myasthenia', 'Myasthenia gravis', 'Myasthenia gravis crisis', 'Myasthenic syndrome', 'Myelitis', 'Noninfectious myelitis', 'Myelitis transverse', 'Autoimmune myocarditis', 'Immune-mediated myocarditis', 'Myocarditis', 'Blood creatine phosphokinase MB increased', 'Troponin increased', 'Autoimmune myositis', 'Immune-mediated myositis', 'Regeneron Pharmaceuticals, Inc.', 'Page 140 of 145', 'CONFIDENTIAL', 'VV-RIM-00146791-1.( Approved - 14 Apr 2021 GMT-5:00']['Clinical Study Protocol', 'R2810-ONC-1676 Amendment 7', 'Myositis', 'Polymyositis', 'Dermatomyositis', 'Autoimmune neuropathy', 'Immune-mediated neuropathy', 'Neuritis', 'Neuropathy peripheral', 'Peripheral sensory neuropathy', 'Polyneuropathy', 'Oral lichen planus', 'Autoimmune pancreatitis', 'Immune-mediated pancreatitis', 'Pancreatitis', 'Pancreatitis acute', 'Paraneoplastic encephalomyelitis', 'Autoimmune pericarditis', 'Pericarditis', 'Polymyalgia rheumatica', 'Pruritus', 'Pruritus allergic', 'Pruritus generalised', 'Pseudopolyposis', 'Psoriatic arthropathy', 'Idiopathic pulmonary fibrosis', 'Regeneron Pharmaceuticals, Inc.', 'Page 141 of 145', 'CONFIDENTIAL', 'VV-RIM-00146791-1.( Approved - 14 Apr 2021 GMT-5:00']\n\n###\n\n", "completion": "END"}